Prostatic adenocarcinoma in a patient with persistent Müllerian duct syndrome

Prostatic adenocarcinoma in a patient with persistent Müllerian duct syndrome

The embryonal male sexual differentiation is driven by testosterone, and Anti-Müllerian hormone (AMH). AMH is responsible for regression of Müllerian ducts in a genetically male fetus. Mutations inactivating AMH or its receptors are responsible for persistent Müllerian duct syndrome (PMDS) in virili...

Full description

Bibliographic Details
Main Authors: Muhammad Umair, Ahsan U Khan, John B Arruda, Dhairya A Lakhani, Ayodele Adelanwa, Yousaf B Hadi, Brian Markovich, Mohamad Waseem Salkini
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Urology Annals
Subjects:
müllerian duct malformation
persistent müllerian duct syndrome
prostate adenocarcinoma
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2022;volume=14;issue=4;spage=398;epage=402;aulast=Umair

Internet

http://www.urologyannals.com/article.asp?issn=0974-7796;year=2022;volume=14;issue=4;spage=398;epage=402;aulast=Umair

Similar Items